These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18565491)

  • 21. [New findings on calcium antagonism].
    Ferrari R; Ceconi C; Curello S; Visioli O
    Ann Ital Med Int; 1992; 7(3 Suppl):100S-111S. PubMed ID: 1338419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium antagonists: current and future applications based on new evidence. Cardio-protective effect of calcium antagonists].
    Hongo K; Yoshimura M
    Clin Calcium; 2010 Jan; 20(1):89-93. PubMed ID: 20048439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-type Ca2+ channels in vascular smooth muscle: multiple functions.
    Cribbs LL
    Cell Calcium; 2006 Aug; 40(2):221-30. PubMed ID: 16797699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of somatostatin on cholecystokinin octapeptide induced bile regurgitation under stress: ionic and molecular mechanisms.
    Si X; Huang L; Luo H; Shi R
    Regul Pept; 2009 Aug; 156(1-3):34-41. PubMed ID: 19445970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E; Van Deusen AL; Vitko I
    J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of flunarizine on T-type calcium channels in mouse spermatogenic cells].
    Wang CS; Gao XH; Cheng H; Gong W; Zhang XC; Cheng J; Gao R; Xiao H
    Zhonghua Nan Ke Xue; 2006 Jul; 12(7):594-7, 601. PubMed ID: 16894933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of L-type calcium channels in arteriolar smooth muscle cells is involved in the pathogenesis of vascular hyporeactivity in severe shock.
    Zhao Q; Zhao KS
    Shock; 2007 Dec; 28(6):717-721. PubMed ID: 17607159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes.
    Furukawa T; Nukada T; Miura R; Ooga K; Honda M; Watanabe S; Koganesawa S; Isshiki T
    J Cardiovasc Pharmacol; 2005 Mar; 45(3):241-6. PubMed ID: 15725949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreasing expression of alpha1C calcium L-type channel subunit mRNA in rat ventricular myocytes upon manganese exposure.
    Yang H; Wang T; Li J; Gu L; Zheng X
    J Biochem Mol Toxicol; 2006; 20(4):159-66. PubMed ID: 16906520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is combined L- and T-channel blockade better than L-channel blockade in therapy?
    Godfraind T
    Hypertension; 2009 Jul; 54(1):e3; author reply e4. PubMed ID: 19433772
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual action of AJG049, a novel gut selective Ca2+ channel antagonist, on Ba2+ currents and contractions in guinea-pig antrum myocytes.
    Zhu HL; Hashimoto M; Teramoto N
    Eur J Pharmacol; 2009 Mar; 605(1-3):138-44. PubMed ID: 19168048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular requirements for L-type Ca2+ channel blockade by testosterone.
    Scragg JL; Dallas ML; Peers C
    Cell Calcium; 2007 Jul; 42(1):11-5. PubMed ID: 17173968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mibefradil--a T-type calcium channel blocker].
    Roguin A; Edoute Y
    Harefuah; 1999 Jan; 136(2):167-9. PubMed ID: 10914190
    [No Abstract]   [Full Text] [Related]  

  • 36. New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.
    Visentin S; Rolando B; Di Stilo A; Fruttero R; Novara M; Carbone E; Roussel C; Vanthuyne N; Gasco A
    J Med Chem; 2004 May; 47(10):2688-93. PubMed ID: 15115410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydropyridine- and voltage-sensitive Ca2+ entry in human parathyroid cells.
    Yokoyama K; Matsuba D; Adachi-Akahane S; Takeyama H; Tabei I; Suzuki A; Shibasaki T; Iida R; Ohkido I; Hosoya T; Suda N
    Exp Physiol; 2009 Jul; 94(7):847-55. PubMed ID: 19346333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channels in chromaffin cells: focus on L and T types.
    Marcantoni A; Carabelli V; Comunanza V; Hoddah H; Carbone E
    Acta Physiol (Oxf); 2008 Feb; 192(2):233-46. PubMed ID: 18021322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydropyridine-insensitive calcium currents contribute to function of small cerebral arteries.
    Kuo IY; Ellis A; Seymour VA; Sandow SL; Hill CE
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1226-39. PubMed ID: 20125181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.